Cerus
CERS
#7651
Rank
โ‚ฌ0.32 B
Marketcap
1,67ย โ‚ฌ
Share price
3.44%
Change (1 day)
-2.87%
Change (1 year)

Cerus (CERS) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ0.13 Billion

According to Cerus's latest financial reports the company's total liabilities are โ‚ฌ0.13 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cerus - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ0.13 B6.02%
2023-12-31โ‚ฌ0.13 B-6.36%
2022-12-31โ‚ฌ0.13 B3.94%
2021-12-31โ‚ฌ0.13 B40.26%
2020-12-31โ‚ฌ95.61 M-1.26%
2019-12-31โ‚ฌ96.83 M40.34%
2018-12-31โ‚ฌ69 M39.61%
2017-12-31โ‚ฌ49.42 M13.79%
2016-12-31โ‚ฌ43.43 M6.4%
2015-12-31โ‚ฌ40.82 M23.34%
2014-12-31โ‚ฌ33.09 M12.62%
2013-12-31โ‚ฌ29.38 M30.4%
2012-12-31โ‚ฌ22.53 M8.19%
2011-12-31โ‚ฌ20.83 M13.4%
2010-12-31โ‚ฌ18.37 M101.79%
2009-12-31โ‚ฌ9.1 M-2.56%
2008-12-31โ‚ฌ9.34 M-25.55%
2007-12-31โ‚ฌ12.54 M11.53%
2006-12-31โ‚ฌ11.25 M-43.01%
2005-12-31โ‚ฌ19.74 M-66.77%
2004-12-31โ‚ฌ59.4 M13.44%
2003-12-31โ‚ฌ52.37 M226.3%
2002-12-31โ‚ฌ16.05 M-34.09%
2001-12-31โ‚ฌ24.35 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Haemonetics
HAE
โ‚ฌ1.36 B 941.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚ฌ2.22 M-98.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
โ‚ฌ16.28 B 12,370.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
โ‚ฌ2.79 M-97.86%๐Ÿ‡บ๐Ÿ‡ธ USA